Which test best predicts chemo risks in seniors? new study aims to find out

NCT ID NCT07163169

Ongoing Knowledge-focused Sponsor: Çanakkale Onsekiz Mart University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at three simple tests—CARG, G8, and a frailty scale—to see which one best predicts chemotherapy side effects in cancer patients aged 65 and older. Researchers will assess 150 patients before they start chemo and track side effects during treatment. The goal is to find the most accurate tool to help doctors make safer treatment decisions for older adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors choose the best screening tool to predict chemotherapy side effects in older adults, leading to safer and more personalized cancer treatment.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve outcomes. The results may not apply to all cancer types or chemotherapy regimens.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GERIATRIC ONCOLOGY ONCOLOGY PHYSIOLOGY

Contacts and locations

Locations

Çanakkale Onsekiz Mart Univercity

Çanakkale, 17020, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.